15th World Bispecific Summit 2024
Evvnt Promotion / evvnt
Archivio
03.09.2024 - 05.09.2024 The Royal Sonesta Boston, 40 Edwin H Land Boulevard, 02142 Cambridge, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
Temi della conferenza
As of 2023, more than 10 bispecific antibodies have been successfully approved by the FDA, and more than 100 are currently in clinical trials, highlighting biopharma’s continued investment within bispecific therapeutics.
As of 2023, more than 10 bispecific antibodies have been successfully approved by the FDA, and more than 100 are currently in clinical trials, highlighting biopharma’s continued investment within bispecific therapeutics.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
URLs:
Brochure: https://go.evvnt.com/2403858-3?pid=4832
Twitter: https://go.evvnt.com/2403858-4?pid=4832
LinkedIn: https://go.evvnt.com/2403858-5?pid=4832
URLs:
Brochure: https://go.evvnt.com/2403858-3?pid=4832
Twitter: https://go.evvnt.com/2403858-4?pid=4832
LinkedIn: https://go.evvnt.com/2403858-5?pid=4832
Informazioni ed Iscrizioni:
https://go.evvnt.com/2403858-2?pid=4832
Ms. Abigail Cox
Oncologia
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
